- Home
- CLBR vs CMPX Comparison
CLBR vs CMPX Comparison
Compare CLBR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLBR
- CMPX
- Stock Information
- Founded
- CLBR 2023
- CMPX 2014
- Country
- CLBR United States
- CMPX United States
- Employees
- CLBR N/A
- CMPX N/A
- Industry
- CLBR
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- CLBR
- CMPX Health Care
- Exchange
- CLBR Nasdaq
- CMPX Nasdaq
- Market Cap
- CLBR 304.5M
- CMPX 291.8M
- IPO Year
- CLBR 2023
- CMPX N/A
- Fundamental
- Price
- CLBR $13.33
- CMPX $2.69
- Analyst Decision
- CLBR
- CMPX Strong Buy
- Analyst Count
- CLBR 0
- CMPX 8
- Target Price
- CLBR N/A
- CMPX $13.13
- AVG Volume (30 Days)
- CLBR 1.7M
- CMPX 809.6K
- Earning Date
- CLBR 01-01-0001
- CMPX 08-11-2025
- Dividend Yield
- CLBR N/A
- CMPX N/A
- EPS Growth
- CLBR N/A
- CMPX N/A
- EPS
- CLBR 0.19
- CMPX N/A
- Revenue
- CLBR N/A
- CMPX $850,000.00
- Revenue This Year
- CLBR N/A
- CMPX N/A
- Revenue Next Year
- CLBR N/A
- CMPX N/A
- P/E Ratio
- CLBR $74.88
- CMPX N/A
- Revenue Growth
- CLBR N/A
- CMPX N/A
- 52 Week Low
- CLBR $10.15
- CMPX $0.77
- 52 Week High
- CLBR $17.47
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- CLBR 51.17
- CMPX 69.49
- Support Level
- CLBR $14.00
- CMPX $2.17
- Resistance Level
- CLBR $17.20
- CMPX $2.49
- Average True Range (ATR)
- CLBR 0.87
- CMPX 0.19
- MACD
- CLBR -0.15
- CMPX 0.02
- Stochastic Oscillator
- CLBR 30.99
- CMPX 89.06
About CLBR Colombier Acquisition Corp. II
Colombier Acquisition Corp II is a blank check company.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.